| Product Name |
Fulvestrant Inhouse Impurity 12 / (7R,8R,9S,13S,14S,17S)-7-(9-chlorononyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Metabolites, Pharmaceutical Standards, Fine Chemicals |
| CAS No |
N/A |
| Catalog Number |
GS.47.FUL.42 |
| Chemical Name/Synonyms |
(7R,8R,9S,13S,14S,17S)-7-(9-chlorononyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate |
| Molecular Weight |
475.11 |
| Molecular Formula |
C29H43ClO3 |
| Purity |
NLT 95 % |
| Applications |
Fulvestrant is used for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women. |
| Inventory Status |
customized
|
